China Considers New Rules to Limit Purchases of Foreign AI Chips Amid Growing Demand 
Proposed Rio Tinto–Glencore Merger Faces China Regulatory Hurdles and Asset Sale Pressure 
TSMC Set to Post Record Q4 Profit as AI Chip Demand Accelerates 
Microsoft Strikes Landmark Soil Carbon Credit Deal With Indigo Carbon to Boost Carbon-Negative Goal 
Walmart International CEO Kathryn McLay to Step Down After Two and a Half Years 
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 
China’s AI Models Narrow the Gap With the West, Says Google DeepMind CEO 
Elon Musk Seeks $134 Billion in Lawsuit Against OpenAI and Microsoft Over Alleged Wrongful Gains 
BYD Shares Rise in Hong Kong on Reports of Battery Supply Talks With Ford 
TSMC Shares Hit Record High as AI Chip Demand Fuels Strong Q4 Earnings 
Rio Tinto and BHP Agree to Explore Major Iron Ore Collaboration in Pilbara 
Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation 
Google Seeks Delay on Data-Sharing Order as It Appeals Landmark Antitrust Ruling 
xAI Restricts Grok Image Editing After Sexualized AI Images Trigger Global Scrutiny 
Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement 
BOWIE, Md., April 19, 2017 -- Inovalon (Nasdaq:INOV), a leading technology company providing advanced, cloud-based platforms empowering a data-driven transformation from volume-based to value-based models across the healthcare ecosystem, today announced that it will hold a conference call for investors on Wednesday, May 3, 2017, at 5:00 p.m. Eastern Time. During the conference call, management will review highlights from the company’s first quarter 2017 financial results, which will be announced via press release after the close of market trading on Wednesday, May 3, 2017.
The conference call can be accessed by dialing (855) 783-2604, conference ID 7550980; international callers should dial (631) 485-4882 using the same ID. The call will be available for replay on Inovalon’s website at www.inovalon.com.
About Inovalon
Inovalon is a leading technology company providing cloud-based platforms empowering a data-driven transformation from volume-based to value-based models throughout the healthcare industry. Leveraging large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and industry-leading subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem. From health plans and provider organizations, to pharmaceutical, medical device, and diagnostics companies, Inovalon’s unique achievement of value is delivered through the effective progression of “Turning Data into Insight, and Insight into Action®.” Providing technology that supports nearly 500 healthcare organizations, Inovalon’s platforms are informed by data pertaining to more than 848,000 physicians, 371,000 clinical facilities, and more than 150 million Americans. For more information, visit www.inovalon.com.
Contacts: Inovalon Kim E. Collins Phone: 301-809-4000 x1473 [email protected] George Price Phone: 301-809-4000 x1190 [email protected]
